Successful Implementation of a Beta Blocker-Free Protocol for CT Coronary Angiography (CTCA) Using a Dual Source CT Scanner

Andrew D. Choi,Nicole Walker,T. TURNER THOMAS,Willington Francis,Shaoqiang Tang,Stuart Barnard,Mariana M. Lamacie,J. Looi,Mansi Turaga,G. Ruvin
DOI: https://doi.org/10.1016/j.hlc.2024.04.274
2024-01-01
Abstract:Beta blockers are commonly given to patients undergoing CTCA to lower heart rate to improve image quality. Patient preparation with beta blocker therapy can be time consuming. We investigated the feasibility of implementing a no beta blocker protocol to improve CTCA workflow. Scan reports were prospectively collected using the ANZACS-QI CT Registry. Scans between June 2022 to November 2022 (regularly using beta blocker) were performed on Siemens 128 Dual source Definition Flash scanner, and scans between June 2023 to November 2023 (not using beta blocker) were performed on Siemens 192 Dual source Definition Force scanner. The percentage of suboptimal image scans, scan repeat rate, scan technique, heart rate (HR) and radiation dose were compared. 1,311 CTCA were performed (617 in 2022 vs 694 in 2023, p<0.0001). 696 (53.1%) were male patients. Mean age: 57.3±11.5 years. Mean BMI: 31.3±8.3 kg/m2. Intravenous beta blockers were used less in 2023, [305 (49.4%) vs 22 (3.2%), p<0.001] and HR was higher (62 vs 67 bpm, p< 0.001). More scans were performed at end systole in 2023 [89 (14.4%) vs 243 (35%), p<0.001]. More suboptimal image quality was seen in 2023 [61 (9.9%) vs 91 (13.1%), p=0.002], however a similar percentage were repeated (15.4% vs 12.4%, p=0.135) and only few were non-diagnostic (6 vs 13, p=0.17). The radiation dose was lower in 2023 (3.4 vs 2.4 mSv, p<0.001). A beta blocker-free protocol was successfully implemented in 2023 with increased scan volumes, reduced radiation exposure, without significantly compromising scan interpretation.
What problem does this paper attempt to address?